Advertisement
Loading...

Clinuvel Pharmaceuticals Limited

CLVLYPNK
Healthcare
Biotechnology
$6.92
$0.08(1.17%)
U.S. Market is Open • 15:30

Clinuvel Pharmaceuticals Limited (CLVLY) Stock Competitors & Peer Comparison

See (CLVLY) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CLVLY$6.84-0.21%344.8M14.55$0.47+0.48%
NONOF$44.72-3.78%199.7B10.43$4.31+3.97%
CSLLY$17.41-0.80%67.5B11.32$1.54+4.16%
UCBJF$289.12-0.02%55B30.59$9.45+0.59%
UCBJY$137.05-1.68%52.2B29.04$4.72+0.62%
ARGNF$803.19+0.00%49.7B35.71$22.49N/A
CMXHF$70.50-0.70%33.8B11.43$6.17+4.14%
IVBXF$10.35-4.17%18B147.86$0.07N/A
WXIBF$4.30+0.00%17.8B25.29$0.17N/A
WXXWY$8.50+3.28%17.6B25.00$0.34N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CLVLY vs NONOF Comparison May 2026

CLVLY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CLVLY stands at 344.8M. In comparison, NONOF has a market cap of 199.7B. Regarding current trading prices, CLVLY is priced at $6.84, while NONOF trades at $44.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CLVLY currently has a P/E ratio of 14.55, whereas NONOF's P/E ratio is 10.43. In terms of profitability, CLVLY's ROE is +0.13%, compared to NONOF's ROE of +0.66%. Regarding short-term risk, CLVLY is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for CLVLY.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions